Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04014764 · ClinicalTrials.gov registry record
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
A clinical trial of Multiple Myeloma and Lymphoma, sponsored by Notable Labs.
- Completed
- Registry status
- 119
- Enrollment target
- 20
- Study locations
NCT04014764: Completed study of Multiple Myeloma and Lymphoma, sponsored by Notable Labs.
NCT04014764 is a study of Multiple Myeloma and Lymphoma that has completed, run by Notable Labs. The registered enrollment target is 119 participants, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04014764, a study of Multiple Myeloma and Lymphoma, has completed, sponsored by Notable Labs.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective, multicenter observational study to collect clinically annotated biospecimens in order to assess the correlation between ex vivo data generated by the Notable assay platform and clinical outcome.
Primary Outcome
Collect clinical responses to treatment and outcomes in patients who have provided samples to the biobank
Conditions Studied
Interventions
- OTHER This is a non-interventional study
Study Locations (20)
Other
- University Hospital of Alexandroupolis - Alexandroupoli
- National Kapodistrian University of Athens - Athens
- Attikon University Hospital - Athens
- National Kapodistrian Hospital/Laikon General Hospital - Athens
- University Hospital of Ioánnina - Ioannina
- University Hospital Patras - Pátrai
- Hospital General Universitario de Alicante - Alicante
- Hospital San Pedro de Alcántare - Cáceres
- Hospital Universitari I Politècnic La Fe - Valencia
California
- CBCC Global Research - Bakersfield
- Pacific Central Coast Health Centers -- SLO Oncology and Hematology Health Center - San Luis Obispo
Florida
- Ocala Oncology Center - Ocala
- Mid Florida Hematology and Oncology Center - Orange City
Colorado
- Colorado West Healthcare System, dba Grand Valley Oncology - Grand Junction
Louisiana
- Touro Infirmary - New Orleans
Maine
- Northern Light Cancer Care Center - Brewer
New York
- New York Cancer and Blood Specialists - Port Jefferson Station
North Carolina
- East Carolina University - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2019-12-15 |
| Est. Completion | 2022-03-31 |
What the finished NCT04014764 record still lists
NCT04014764 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (78% lower).
The record links to 7 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 1 intervention - of which This is a non-interventional study is the first listed.
NCT04014764 names 20 study sites across 10 states, led by Other, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04014764 about?
NCT04014764 is a clinical study titled "Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy". This is a prospective, multicenter observational study to collect clinically annotated biospecimens in order to assess the correlation between ex vivo data generated by the Notable assay platform and clinical outcome.
What is the current status of trial NCT04014764?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2019-12-15. Estimated completion is 2022-03-31.
What conditions does trial NCT04014764 study?
This clinical trial studies the following conditions: Multiple Myeloma, Lymphoma, Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia, Myeloproliferative Neoplasm.
What interventions are being tested in trial NCT04014764?
The interventions under investigation include: This is a non-interventional study (OTHER).
Who is sponsoring clinical trial NCT04014764?
This trial is sponsored by Notable Labs, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04014764 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Louisiana, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04014764's enrollment target sits among peer trials
119 156th of 438 higher than 283 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI